Detalhe da pesquisa
1.
PREVES: A Population-Based Survey Focused on Cancer and Nutrition.
Oncology
; 101(6): 369-374, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054688
2.
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study.
Oncology
; 100(9): 505-511, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839299
3.
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial.
Oncology
; 100(9): 512-518, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817009
4.
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.
Oncology
; 98(10): 743-747, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32570240
5.
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.
Oncol Ther
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416326
6.
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario.
Oncol Ther
; 12(1): 147-155, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112965
7.
Effective Management of Nasal Vestibule Squamous Cell Carcinoma with Cemiplimab: A Case Report.
Case Rep Oncol
; 16(1): 935-938, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37900804
8.
Mediterranean Diet as a Supportive Intervention in Cancer Patients: Current Evidence and Future Directions.
Curr Oncol
; 29(10): 7579-7582, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36290874
9.
Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma.
Front Oncol
; 10: 579914, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33194706
10.
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
Crit Rev Oncol Hematol
; 152: 102991, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544802
11.
Combined HAT/EZH2 modulation leads to cancer-selective cell death.
Oncotarget
; 9(39): 25630-25646, 2018 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29876013
12.
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
Clin Cancer Res
; 23(10): 2542-2555, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27358484
13.
Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?
Front Med (Lausanne)
; 7: 189, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32435648